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Toll-like receptors (TLRs) can recognize microbial patterns and utilize adaptor molecules,
such as-MyD88 or (TRIF TIR-domain-containing adapter-inducing interferon-β), to initi-
ate downstream signaling that ultimately affects the initiation of adaptive immunity. In
addition to this inflammatory role, TLR5 expression on dendritic cells can favor antigen
presentation of flagellin peptides and thus increase the sensitivity of flagellin-specific
T-cell responses in vitro and in vivo. Here, we examined the role of alternative signaling
pathways that might regulate flagellin antigen presentation in addition to MyD88. These
studies suggest a requirement for spleen tyrosine kinase, a noncanonical TLR-signaling
adaptor molecule, and its downstream molecule CARD9 in regulating the sensitivity of
flagellin-specific CD4+ T-cell responses in vitro and in vivo. Thus, a previously unap-
preciated signaling pathway plays an important role in regulating the dominance of
flagellin-specific T-cell responses.
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Introduction
Innate immune receptors are part of the first line of host defense
and protect against foreign pathogens [1, 2]. The surface of
innate immune cells is decorated with multiple receptors, includ-
ing pattern-recognition receptors (PRRs) and scavenging recep-
tors, that together can recognize an invading pathogen, generate
a local inflammatory response. PRRs are able to sense the presence
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of conserved microbial molecules, including proteins, lipopolysac-
charides, lipoproteins, and nucleic acids [1, 2]. Importantly, PRR-
mediated ligand recognition can modulate the activation status of
dendritic cells (DCs) and the subsequent ability of this population
to initiate an adaptive immune response [3, 4]. Although there are
13 different Toll-like receptors (TLRs) described in humans [5],
only TLR5 and TLR11 predominantly recognize protein ligands
[6, 7]. Since host T cells also directly recognize protein fragments,
this creates a unique situation where a TLR and the responding
T-cell population can directly recognize the same microbial lig-
and. It is currently unclear how this overlapping innate immune
response to the same protein ligand might affect the quantity and
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quality of the adaptive immune response to TLR5 or TLR11
ligands.
TLR ligation initiates a cascade of signaling events that utilizes
several different intracellular adapter proteins. With the excep-
tion of TLR3, which requires TIR-domain-containing adapter-
inducing interferon-β, all TLRs can initiate downstream sig-
nals through myeloid differentiation factor 88 (MyD88), while
TLR4 can independently engage both MyD88 and TIR-domain-
containing adapter-inducing interferon-β [8]. TLR5 is expressed
by a variety of cell types and is known to regulate innate and
adaptive immune responses to bacterial flagellins [9–12]. Binding
of flagellin to TLR5 initiates receptor dimerization, allowing the
TIR domains of TLR5 to interact with the TIR domain of MyD88.
MyD88 subsequently transmits this signal by initiating a cascade
of signaling events that recruits interleukin-1 receptor-associated
kinase (IRAK)1/4, TAK, TBK, MEK, JNK to ultimately induce the
transcription of genes through NF-kB or AP-1 [8].
C-type lectin receptors (CLRs) are another class of PRRs that
appear to primarily recognize fungal components and can also
regulate host inflammatory responses and influence infection-
associated pathology [13]. Signaling downstream of CLR ligation
is most clearly understood for Dectin-1, a receptor that recog-
nizes fungal β-glucans [14]. Dectin-1 ligation induces MyD88-
independent phosphorylation of an immune receptor tyrosine-
based activation-like motif (ITAM-like) and recruits and activates
spleen tyrosine kinase (Syk) that ultimately causes downstream
activation of NF-kB [15–17]. Besides TLRs and CLRs, Nod-like
receptors (NLRs) are an additional class of PRR that function
as intracellular sensors of pathogens that can regulate pathways
independently of MyD88 and induce NF-kB and the generation
of proinflammatory molecules [18]. Recently, Syk has also been
shown to regulate inflammasome-mediated formation of adaptor
protein ASC (apoptosis associated speck-like protein containing a
CARD), an important step that controls responses via NLRs. There-
fore, signals through Syk can regulate the function of CLRs and
additionally affect NLRP3 (NACHT, LRR and PYD domain con-
taining protein 3) inflammasome-mediated IL-18 secretion and
caspase-1 activity in macrophages [19]. However, Syk is largely
dispensable for NACHT, LRR and PYD domain containing protein
3 inflammasome activation in DCs, suggesting that Syk can play
different roles in different immune cell types [20].
Flagellin is the primary protein component of bacterial flagella,
a whip-like appendage that is found on the surface of both gram-
positive and gram-negative bacteria and assists bacterial locomo-
tion and adherence to host epithelium [21]. Flagellin is directly
recognized by TLR5 to generate an inflammatory response and
can also elicit a robust adaptive immune response even when
nanograms quantities are injected into an animal [6, 22, 23].
Although flagellin can also be recognized by the intracellular sen-
sors Naip5 and NLRC4 [24], the ability of flagellin to initiate a
robust adaptive immune response at very low concentrations has
been shown to be highly dependent upon the expression of TLR5
[12].
Previous studies in our laboratory have demonstrated that
TLR5 is required but that MyD88 is dispensable for the induction
of CD4+ T-cell activation responses to low concentrations of flag-
ellin [12], however, it is currently unclear how such responses via
TLR5 occur in the absence of MyD88. Here, we demonstrate Syk
and CARD9 signaling pathways can influence TLR5-mediated anti-
gen presentation and that Syk and CARD9 expression are required
for optimal activation of flagellin-specific CD4+ T cells. These data
suggest the presence of signaling pathways that are downstream
of TLR5 or another coreceptor that can participate in antigen pre-
sentation of flagellin epitopes.
Results
TLR5 is required for robust initial activation of
flagellin-specific T cells
Previous reports have shown that TLR5-deficient DCs have
impaired ability to activate flagellin-specific SM1 T cells when
flagellin protein is used as an antigen [12]. Importantly, TLR5-
deficient and wild-type (WT) DCs displayed equivalent ability to
activate SM1 T cells in response to a wide range of flagellin pep-
tide, or OT-II T cells in response to ovalbumin (OVA) [12]. To
examine this phenomenon inmore detail, wemonitored the ability
of WT, TLR5-, or MyD88-deficient splenic DCs to activate flagellin-
specific T cells at different time points over a 24-h period. WT,
TLR5-, and MyD88-deficient DCs were each able to activate SM1
T cells efficiently when processed flagellin peptide was added to in
vitro cultures, causing increased surface expression of CD69 and
CD25 and secretion of IL-2 (Fig. 1A, B, and D). Thus, the DC pop-
ulations from TLR5- and MyD88-deficient mice have similar stim-
ulatory ability for SM1 T cells when compared directly to WT DCs.
However, when these same DCs were exposed to whole flagellin
that requires processing before antigen presentation can occur,
a striking requirement for DC expression of TLR5 was observed.
Thus, incubation of SM1 T cells with WT DCs and flagellin stim-
ulated increased surface expression of CD69 and CD25 on SM1
T cells within 3 and 9 h, respectively (Fig. 1A and B). In contrast
SM1 T cells incubated with TLR5-deficient DCs did not increase
expression of CD69 or CD25 at all in the first 12 h of culture
(Fig. 1A and B). Similarly, WT DCs induced the production of IL-2
from SM1 T cells within 6 h of culture, while TLR5-deficient DCs
were unable to induce IL-2 production during this time period
(Fig. 1C). After 24 h of culture, TLR5-deficient DCs induced a
small amount of IL-2, but this was still considerably less than
detected in WT DC cultures (Fig. 1C). Increased surface expres-
sion of CD69 and CD25 was also detected on SM1 T cells incu-
bated with MyD88-deficient DCs, however, a delay in the kinetics
of this response was noted when compared directly to WT DCs
(Fig. 1A and B). Similarly, IL-2 production from MyD88-deficient
DC cultures was elevated when compared to TLR5-deficient DC
cultures, but still low when compared to WT DCs (Fig. 1C). These
experiments confirm that TLR5 is required for robust activation
of flagellin-specific T cells to whole flagellin. In contrast, MyD88
expression is not required for initial SM1 T-cell activation, but can
contribute to the rapid kinetics of this response in vitro.
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Figure 1. TLR5 is essential for activation of flagellin-specific T cells at low dose of flagellin. Time kinetics was performed to evaluate the activation
of flagellin-specific SM1 T cells (CD4+CD90.1+) in vitro, using CD69 and CD25 as markers of activation. CD11c+ DCs were purified from spleens of
WT (white bars), TLR5-deficient (gray bars), and MyD88-deficient DCs (black bars), using DC enrichment kits and were cultured in 1:1 ratio with
flagellin-specific SM1 T cells in the presence of flagellin (1 ng/mL), peptide (6 μM), andmedium alone for 3, 6, 9, 12, and 24 h. (A and B) The activation
of flagellin-specific T cells as determined by (A) CD69 expression and (B) CD25 expression at given time points, was measured by flow cytometry.
Data are shown as mean + SEM of three samples per group, and are from one experiment, representative of two independent experiments.
(C and D) Concentration of IL-2 in DC culture supernatants at 3, 6, 9, 12, and 24 h, as measured by ELISA. CD11c+ DCs purified from spleens of WT
(filled circles), TLR5-deficient (filled squares), and MyD88-deficient DCs (filled triangles) using DC enrichment kits and were cultured in 1:1 ratio
with flagellin-specific SM1 T cells in the presence of (C) flagellin (1 ng/mL) or (D) peptide (6 μM) for 3, 6, 9, 12, and 24 h. Data are shown as mean
± SEM of three samples per group carried out in tissue culture replicates, and are from one single experiment representative of two independent
experiments. NS: nonsignificant by unpaired t-test.
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Table 1. Protein phosphorylation after flagellin stimulationa)
Protein phosphorylated Estimated fold change,
f = F (WT, Myd88) – F (TLR5)
WT Myd88 deficient
PKCd 0.70 0.92
Tyro10 (DDR2) 0.66 0.77
Kit 1.12 0.74
CASP1 2.46 1.78
IRS1 1.13 0.96
GSK3b 2.50 3.74
TEK (TIE2) 1.40 1.20
Syk 5.51 5.28
a)DCswere isolated fromWT, TLR5-deficient, andMyD88-deficientmice
and stimulated with flagellin (5 μg/mL) for 15 min. Protein phos-
phorylation was determined in cell lysates with a Kinex antibody
microarray, containing a panel of phospho-specific antibodies to pro-
vide a broad overview of intracellular phosphorylation. Estimated
fold change (f) is calculated by subtracting the fold change values
observed in TLR5-deficient samples (control, F-TLR5) from WT (F-Wt)
and MyD88-deficient (F-Myd88) samples. Fold change (F) is the Z ratio
of treated over untreated samples.
Examination of protein phosphorylation after TLR5
ligation
TLR5 ligation induces the secretion of inflammatory mediators
as a result of downstream signaling through MyD88, IRAK1/4,
and other adaptors [8]. In order to identify other signal-
ing molecules that might be engaged downstream of TLR5 in
the absence of MyD88, we initially probed a Kinex antibody
microarray containing a panel of phospho-specific antibodies to
provide a broad overview of intracellular phosphorylation. Lysates
were prepared from WT, TLR5-, and MyD88-deficient DCs acti-
vated in the presence of flagellin and assayed for protein phos-
phorylation. This screening approach highlighted several poten-
tial signaling molecules with increased phosphorylation in WT
andMyD88-deficient DCs incubated with flagellin when compared
to TLR5-deficient DCs (Table 1). To confirm this initial screen,
we used standard Western blotting to individually monitor phos-
phorylation changes in WT DC lysates after flagellin stimulation.
However, using this conventional approach, we did not detect
consistent or significant changes in the phosphorylation of these
proteins in response to flagellin (Fig. 2A). In contrast, we were
able to detect a small amount of TLR5-dependent phosphoryla-
tion of Syk by flow cytometry after WT DCs were incubated with
flagellin and importantly this response was consistently reduced
in TLR5-deficient DCs (Fig. 2B to D). These data suggested that
flagellin might initiate Syk phosphorylation in a TLR5-dependent
manner.
Inhibition of Syk reduces TLR5-dependent antigen
presentation
As a complementary approach to direct examination of protein
phosphorylation, we monitored the effect of inhibiting different
Figure 2. Flagellin induces phosphorylation and upregulation of
molecules in DCs independently of MyD88. CD11c+ splenic DCs were
enriched from WT, TLR5-deficient, and MyD88-deficient mice and
treated with flagellin. (A) Whole cell lysates of CD11c+ DCs treated
with flagellin (5 μg/mL) for 15 min and untreated control were ana-
lyzed by immunoblotting for caspase-1, IRS-1, PKC-d, DDR2, TEK,
and b-actin (loading control). (B) Representative flow cytometry plots
(n = 3 per group) show intracellular staining for Syk phosphorylation
in WT and TLR5-deficient DCs treated with flagellin (10 ng/mL, dashed
line histogram) or untreated (solid line histogram). Shaded histogram
shows isotype control staining. (C and D) CD11c+ DCs from WT or
TLR5-deficient mice were either treated with flagellin or left untreated.
(C) The percentage and (D) MFI (mean fluorescence intensity) of phos-
phorylated Syk in CD11c+ DCs was determined by flow cytometry. Data
are shown as mean + SEM of three samples per group, and are from a
single experiment representative of two independent experiments. NS:
nonsignificant by unpaired t-test.
signaling pathways during TLR5-dependent antigen presentation
of flagellin to SM1 T cells. As expected, WT DCs were able to
activate SM1 T cells in vitro to increase surface expression of
CD69 and produce IL-2, when peptide or whole flagellin was
added to cultures (Fig. 3A, top row). The addition of IRAK1/4
(IRAK1/4 inhibitor), p38 MAP kinase (SB203580), or p42/44
mitogen-activated protein kinase (MAPK (PD98059) inhibitors to
DCs had no discernable effect on their ability to induce CD69
expression on SM1 T cells incubated with whole flagellin or pep-
tide (Fig. 3A). However, each of these inhibitors was able to block
IL-6 production in cultures, indicating that DC activation via TLR5
ligation was effectively inhibited (Fig. 3B). In marked contrast,
the addition of a Syk inhibitor (BAY 61–3606) completely blocked
the ability of DCs to induce CD69 expression on SM1 T cells and
IL-2 production in response to flagellin protein (Fig. 3C to E).
Importantly, the inhibition of Syk had no effect on SM1 T-cell
stimulation in response to peptide (Fig. 3C to E), demonstrating
that Syk is only necessary when antigen processing is required.
Syk and CARD9 are required for optimal antigen
presentation to flagellin-specific T cells
Syk-deficient mice do not survive to full gestation, but a require-
ment for Syk in DC antigen presentation can be examined by
C© 2014 The Authors. European Journal of Immunology published by
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Figure 3. Syk is required for optimal activation of DCs and flagellin-specific T cells. (A) The role of IRAK1/4, p38, and p42/44 MAPK was examined
by inhibition with 50 μM of specific pharmacological inhibitors IRAK1/4 inhibitor, p38 MAPK inhibitor (SB203580), and p42/44 MAPK inhibitor
(PD98059). In total, 1 × 105 CD11c+ DCs were treated with inhibitors or left untreated for 30 min before incubation with 1 × 105 SM1 T cells,
10 ng/mL of flagellin, or 6 μM of flagellin peptide (427–441). SM1 (CD4+CD90.1+) T-cell activation was determined as CD69 expression by flow
cytometry 16 h after flagellin stimulation. (B) IL-6 production was assayed in culture supernatants of DCs treated with various pharmacological
inhibitors asmentioned above and culturedwith SM1T cells in a 1:1 ratio for 16 h by ELISA. (C) CD11c+ DCswere pretreatedwith 1μMof Syk inhibitor
(Bay IV 61–016) or DMSO before incubating with 1 × 105 SM1 T cells flagellin or peptide stimulation. Representative flow cytometry plots (n = 3
samples per group) show CD69 expression on (CD4+CD90.1+) SM1 T cells 16 h after flagellin or peptide stimulation, as measured by flow cytometry.
(D) The percentage of CD69 expression asmeasured in (C). (E) Production of IL-2 in culture supernatants was assessed by ELISA 16 h after incubation
with medium, flagellin, peptide, in the presence or absence of Syk inhibitor. (B, D, and E) Data are shown as mean ± SEM of three samples per
group, and are from one single experiment representative of two independent experiments. NS: nonsignificant by unpaired t-test.
using fetal liver chimeras [25]. We generated WT and Syk-
deficient fetal liver chimeric mice and then tracked the in vivo
response of SM1 T cells to flagellin immunization. Although SM1
T cells remained able to respond to flagellin immunization in
Syk-deficient chimeras, CD4+ T-cell clonal expansion was signifi-
cantly lower than observed in WT chimeras and there was a clear
reduction in total SM1 T cells in the absence of Syk (Fig. 4A to
C). Furthermore, there was also a small reduction in CFSE dye-
dilution by SM1 T cells stimulated in Syk-deficient versus WT
chimeras (Fig. 4D and E).
Given the modest impact of Syk deficiency on SM1 T cells
in vivo, it remained possible that some WT APCs transferred to
chimeras during the T-cell adoptive transfer process were respon-
sible for some of the T-cell response. To address this limitation, we
directly examined the ability of enriched DCs from Syk-deficient
chimeras to activate SM1 T cells in vitro. In order to have an inter-
nal control for these experiments, we simultaneously examined the
ability of OT-II T cells to respond to OVA added to the same cul-
tures. In these cultures, Syk-deficient DCs displayed a significantly
lower ability than WT DCs in activating SM1 T cells to increase
surface expression of CD69 or CD25 when flagellin protein was
added to cultures (Fig. 5A to D). In contrast, Syk-deficient DCs
remained able to activate SM1 T cells when peptide was added to
cultures (Fig. 5A to D). Furthermore, the addition of an antibody
C© 2014 The Authors. European Journal of Immunology published by
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Figure 4. Syk deficiency hinders robust activation of SM1 T cells in vivo. (A) In total, 1 × 106 CFSE-stained SM1 T cells were adoptively transferred
into WT and Syk-deficient chimeric mice and the following day were immunized with 1 μg of flagellin. Three days later, clonal expansion of SM1
T cells was examined in the spleen by flow cytometry. Representative flow cytometry plots (n = 3 mice per group) are shown. (B and C) WT or
Syk-deficient mice were immunized with flagellin (1 μg) and (B) the percentage and (C) total number of SM1 T cells in the spleens was determined
by flow cytometry. Data are shown as mean + SEM of three mice per group, and are from a single experiment representative of three independent
experiments. NS: nonsignificant by unpaired t-test. (D and E) SM1 T-cell proliferation in WT and Syk-deficient mice was examined by CFSE dye
dilution. (E) WT (solid line), Syk-deficient mice (dotted line). Shaded area shows isotype control staining. Representative flow cytometry plots
(n = 3 mice per group) are shown and are from one single experiment representative of three independent experiments.
specific for TLR5 was able to block antigen presentation of flag-
ellin to SM1 T cells (Fig. 5A to D), demonstrating that the antigen
presentation in this culture is TLR5-dependent. In addition, cul-
tures containing Syk-deficient DCs induced lower amounts of IL-2
production from SM1 T cells, when compared to WT DCs (Fig. 5I).
In these same cultures, both WT and Syk-deficient DCs were able
to activate OVA-specific OT-II T cells to increase the expression of
CD69 and CD25 (Fig. 5E to H). Thus, the absence of Syk causes a
specific deficiency in the ability of DCs to present flagellin to CD4+
T cells.
CARD9 is a proteinmolecule that is downstream of the Dectin-1
/Syk signaling pathway where it engages the Bcl-10-MALT1 com-
plex to initiate transcription of genes involved in inflammation
[26]. Given the requirement for Syk in the in vitro experiments
above, we also decided to examine the role of CARD9 in DC acti-
vation of flagellin-specific T cells. When cultured with flagellin
protein, CARD9-deficient DCs were completely unable to induce
upregulation of CD69 and CD25 on SM1 T cells (Fig. 6A to D).
However, as observed with TLR5- and Syk-deficient DCs, the addi-
tion of processed flagellin peptide allowed both CARD9-deficient
and WT DCs to efficiently activate SM1 T cells in vitro (Fig. 6A
to D). Interestingly, this effect of CARD9 deficiency appeared to
be greater than the more modest effect of Syk deficiency, sug-
gesting that other signaling pathways may remain able to activate
CARD9 in the absence of Syk. Together, these data demonstrate
that both Syk and CARD9 are required for optimal processing of
whole flagellin for presentation to SM1 T cells.
Discussion
Flagellin is an unusual molecule in that it is directly recognized
by the receptors of the host innate and adaptive immune system
[9–12]. Previous studies have demonstrated that TLR5-deficient
mice have reduced antibody and T-cell responses to injected flag-
ellin, but that a requirement for TLR5 is most clearly observed at
low antigen concentrations [9–12]. Indeed, the sensitivity of mam-
malian adaptive immune responses to small quantities of flagellin
initially led to the use of this antigen in many older immunologi-
cal studies [6, 22, 23]. Our laboratory recently reported that host
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Figure 5. Syk-deficient DCs display a specific deficiency in the activation of flagellin specific CD4+ T cells. CD11c+ DCs (1 × 105) isolated
from WT and Syk-deficient chimeric mice were either pretreated with monoclonal anti-TLR5 antibody for 60 min or left untreated and were
then cultured with 1 × 105 SM1 or OT-II T cells for 16 h in the presence of OVA (100 μg/mL), OVA (100 μg/mL) + flagellin (1 ng/mL), or flagellin pep-
tide (6 μM). (A and B) Representative flow cytometry plots (n = 3 samples per group) show the expression of (A) CD69 and (B) CD25 on (CD4+CD90.1+)
SM1 T cells. (C and D) The percentage of (C) CD69- and (D) CD25-expressing SM1 T cells as treated in (A and B). (E and F) Representative flow cytom-
etry plots (n = 3 samples per group) show the expression of (E) CD69 and (F) CD25 on (CD4+CD90.1+) OT-II T cells cultured with treated CD11c+ DCs
enriched from spleen of WT and Syk-deficient chimeric mice as described above. (G and H) The percentage of (G) CD69- and (H) CD25-expressing
OT-II T cells as treated in (E and H). (I) IL-2 concentration was measured in the culture supernatant of DC T-cell coculture experiments (16 h) by
ELISA. (C, D, G, H, I) Data are shown as mean + SEM of three samples per group, and are from one experiment representative of three independent
experiments. NS: nonsignificant by unpaired t-test.
immune sensitivity to flagellin is mediated by TLR5 expression
and that surprisingly this pathway displays limited dependence on
MyD88, the only known adaptor protein used by TLR5. Therefore,
our goal in this study was to examine whether other signaling
pathways were required for the processing and presentation of
flagellin protein to flagellin-specific CD4+ T cells.
Unlike TLRs, CLR ligation initiates phosphorylation of Syk
and resulting signals utilize CARD9 in a pathway that eventually
leads to a proinflammatory response [13, 26]. Specifically, in the
absence of CARD9 or Syk, DCs were unable to robustly activate
flagellin-specific T-cell responses. Thus, our data suggest that a
similar pathway is operational during flagellin processing by DCs,
although the exact intersection of Syk and CARD9 with the TLR5
pathway is currently unclear. Since the presentation of flagellin to
T cells at low antigen doses is TLR5-dependent and an anti-TLR5
antibody blocked presentation in our assays, one possibility is that
C© 2014 The Authors. European Journal of Immunology published by
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Figure 6. CARD9-deficient DCs display impaired
ability to activate flagellin-specific T cells. CD11c+
DCs were enriched from the spleens of WT and
CARD9-deficient mice. (A–D) In total, 1 × 105 DCs
were cultured with 1 × 105 SM1 T cells in the
presence of flagellin (10 ng/mL), peptide (6 μM),
or medium alone for 16 h, and T-cell activation
measured by flow cytometry. (A) T-cell activa-
tion was analyzed by measuring CD69 expression
on gated SM1 T cells (CD4+CD90.1+) in the pres-
ence of WT (top) or CARD9-deficient (bottom) DCs.
(C) The percentage of CD69+ SM1 T cells cul-
tured with WT (white bars) or CARD9-deficient
(black bars) DCs is shown. (B) T-cell activation
was analyzed by measuring CD25 expression on
gated SM1 T cells (CD4+CD90.1+) in the presence
of WT or CARD9-deficient DCs. (D) The percent-
age of CD25+ SM1 T cells cultured with WT (white
bars) or CARD9-deficient (black bars) DCs is shown.
Histograms are representative of two individual
experiments done in triplicate. (C and D) Data are
shown as mean + SEM of three samples per group,
and are from one experiment representative of two
independent experiments. NS: nonsignificant by
unpaired t-test.
TLR5 signals downstream using a CLR-like pathway to enhance
antigen presentation of bound ligands (Fig. 7A). However, an
alternative possibility is that a coreceptor is recruited following
TLR5 ligation and specifically participates in the enhancement
of flagellin uptake and antigen processing via Syk and CARD9
signaling pathways (Fig. 7B). A final possibility is that TLR5 liga-
tion initiates flagellin uptake independent of Syk and CARD9, but
that the processing of flagellin epitopes requires Syk and CARD9
pathways (Fig. 7C). The generation of new reagents to visualize
flagellin/TLR5 trafficking in APCs will be required to discriminate
between these different possibilities. It is of interest that the effect
of Syk deficiency was considerably milder than that observed for
CARD9 deficiency, perhaps indicating that there are other signal-
ing pathways that can also converge on CARD9 in the absence of
Syk. An involvement of Syk/CARD9 in flagellin antigen process-
ing would be consistent with the known role of CLRs, which have
been shown to utilize Syk-dependent pathways to enhance anti-
gen presentation of bound ligands [27]. Given this similarity, it is
tempting to speculate that any antigen that is conjugated to a TLR
ligand may be able to preferentially enhance subsequent antigen-
specific T-cell responses in a process that is fundamentally distinct
from the well-described adjuvant effects of TLR ligands.
Flagellin can function as a potent adjuvant and DCs are acti-
vated within hours of injection of purified flagellin into na¨ıve mice
[28, 29]. Depending on the dose or route of flagellin adminis-
tration, this adjuvant effect can lead to the generation of Th1-
or Th2-like adaptive responses and can require the expression of
TLR5 or the cytoplasmic flagellin sensor NLRC4 [30–35]. How-
ever, the exquisite sensitivity of CD4+ T cells to low-dose flag-
ellin administration is solely dependent on the expression of TLR5
[11, 12]. Our experiments examining the early kinetics of T-cell
activation have revealed that, although MyD88 is not required
for flagellin-specific T-cell activation, it does play an important
role in accelerating early T-cell activation, presumably as a result
of previously described MyD88-dependent effects on DC costim-
ulation and cytokine production [36]. Together these data sug-
gest a model where flagellin ligation of TLR5 initiates a MyD88-
dependent pathway that leads to DC activation and that this occurs
simultaneously with a Syk-dependent pathway that encourages
antigen presentation. The overall contribution of flagellin TLR5
binding to flagellin-specific T-cell activation is likely to be a result
of both of these pathways working together.
Understanding the signaling pathways present downstream of
TLRs is an important objective since they contribute to sepsis [37]
and other inflammatory disorders [38]. TLRs have previously been
shown to interact with CLR signaling during fungal recognition,
where zymosan binds to both TLR and Dectin-1 and initiates
both MyD88-dependent and MyD88-independent signaling path-
ways simultaneously [39]. It is clear that binding of flagellin to
TLR5 initiates a signaling cascade through MyD88 that leads to
the secretion of proinflammatory cytokines and recruitment of
phagocytic cells to mediate pathogen clearance [40, 41]. How-
ever, our studies here demonstrate that Syk-dependent signals are
also initiated following TLR5 ligation and that MyD88 expression
is not essential for antigen presentation that leads to flagellin-
specific T-cell activation. This alternative-signaling pathway after
TLR5 ligation has not previously been reported, but we specu-
late that this is because almost all previous studies have focused
on innate inflammation. In contrast, our studies have specifically
examined the contribution of TLR5 to the initiation of flagellin-
specific adaptive immune responses. It is important to note that all
of our DC and T-cell assays demonstrate no antigen-presentation
deficiency when a flagellin peptide or OVA antigen presentation
is examined [12], thus the contribution of the Syk-, CARD9-
dependent pathway is only observed when examining CD4+ T cell
responses to whole flagellin. While this may appear to be a rel-
atively unique situation, this preferential treatment of flagellin
may have specifically evolved to provide a rapid adaptive immune
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Figure 7. Proposed model for Syk and CARD9 involvement in TLR5-
mediated flagellin antigen presentation. DCs expressing TLR5 can
engage a noncanonical pathway via Syk and CARD9 to enhance flagellin
specific T-cell activation. This may be the result of (A) direct signals via
TLR5 to the Syk andCARD9pathway to enhanceflagellin processing and
MHC class II loading during maturation of the phagosome/lysosome.
This enhanced processing results in enhanced TCR ligation, upreg-
ulation of IL-2 production, and subsequent T-cell clonal expansion.
(B, C) Alternatively, either (B) a Syk/CARD9 pathway may enhance flag-
ellin processing downstreamof a TLR5 coreceptor, or (C) Syk andCARD9
activation occurs during flagellin processing in the phago/lysosome,
following Syk-independent, TLR5-mediated uptake of flagellin.
response to flagellated microbes and may explain the dominance
of flagellin-specific responses noted in inflammatory bowel disease
[42, 43].
In conclusion, our study suggests the presence of a Syk- and
CARD9-dependent pathway that operates in conjunction with
TLR5 ligation to enhance flagellin antigen presentation. Future
examination of this pathway could be important in the devel-
opment of vaccines for flagellated microbes and understand-
ing the initiation of flagellin-specific responses in inflammatory
disease.
Materials and methods
Mice and reagents
C57BL/6 and B6.SJL-PtprcaPep3b/BoyJ (CD45.1 congenic) mice
(6–8 weeks old) were purchased from The Jackson Laboratory
(Bar Harbor, Maine, USA) and NCI (Frederick, MD). TLR5-
deficient [44, 45] and MyD88-deficient [46] mice were bred from
breeder stock originally provided by Dr. A. Gewirtz (Georgia State
University, GA) and Dr. S. Way (University of Minnesota Medi-
cal School, MN). Rag-deficient, CD90.1 congenic, flagellin-specific
SM1 TCR transgenic mice were bred in our facility and have pre-
viously been described in detail [47, 48]. Rag-deficient, OT-II TCR
transgenic mice [49] were backcrossed to a Rag-deficient CD90.1
congenic background in our laboratory. CARD9-deficient [50] and
Syk-deficient [25] mice were bred at the University of Texas MD
Anderson Cancer Center and the MRC National Institute for Med-
ical Research.
The flagellin epitope recognized by SM1 T cells
(flagellin427–441) has previously been reported [51], and this
peptide was purchased from Invitrogen Corporation (Carlsbad,
CA). Ultrapure LPS was purchased from Alexis Biochemicals
(Farmingdale, NY). Signaling pathway inhibitors SB203580
(4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-
imidazole), PD98059 (2′-amino-3′-ethoxyflavone), IRAK1/4
inhibitor (N-(2-morpholinylethyl)-2-(3-nitrobenzoylamido)-
benzimidazole), and BAY 61–3606 (2-(7-(3,4-dimethoxyphenyl)-
imidazo [1,2-c] pyrimidin-5-ylamino)-nicotinamide, HCl) were
purchased from EMD Biosciences (Gibbstown, NJ).
Fetal liver chimeric mice
WTand Syk-deficient chimericmicewere generated by IV injection
of 1 × 106 WT or Syk-deficient fetal liver cells [25] into B6.SJL-
PtprcaPep3b/BoyJ (CD45.1 congenic) mice. Recipient mice were
lethally irradiated with 2 × 600 rads using a 137Cs source before
reconstitution. Reconstituted mice were treated with antibiotics
for 8 weeks and the degree of chimerism (CD45.1 versus CD45.2)
confirmed before use in in vitro and in vivo experiments.
Bacterial strains and flagellin production
LPS-deficient Salmonella serovar Typhimurium X4700, provided
by Dr. R. Curtiss (Arizona State University, Tempe, AZ), was used
to purify flagellin using a modified acid-shock protocol. Overnight
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LB broth cultures were centrifuged, washed, and resuspended in
PBS before acid treatment to liberate flagellin. Monomeric flagellin
was prepared by depolymerizing dialyzed samples at 70°C for 1 h
and passed through endotoxin removal columns (Pierce Biotech-
nology, Rockford, IL). Flagellin purity was determined using silver-
stained SDS gels and endotoxin detection kits (Sigma, St. Louis,
MO). Our flagellin preparations have previously been shown to
have identical biological activity to recombinant flagellin produced
in eukaryotic cells [10].
Adoptive transfer and immunization
Single cell suspensions were prepared after harvesting spleen,
inguinal, brachial, cervical, andmesenteric lymph nodes from SM1
TCR transgenic mice and red blood cells were lysed using ACK lysis
buffer (Lonza, Walkersville, MD) before labeling with CFSE [52].
The frequency of SM1 T-cell was determined by flow cytometry
before 0.8 – 1 × 106 cells were transferred IV into recipient mice.
The following day, mice were injected IV with flagellin and SM1
T cell expansion examined at various times afterward.
DC isolation and in vitro stimulation
CD11c+ DCswere isolated from spleens digested using collagenase
D (Roche Diagnostics, Indianapolis, IN), as previously described
[10] and enriched to greater than 85–95% purity using CD11c
microbeads (Miltenyi Biotech, Inc., Auburn, CA). Enriched DCs
(1 × 105 cell/well) were incubated in 96-well plates in a 1:1
ratio with SM1 or OT-II T cells in the presence or absence of
added antigen. CD4+ T cells were recovered at 3, 6, 9, 12, 16, and
24 h time points after stimulation to examine T-cell activation and
cytokine production. For inhibition assays, DCs were pretreated
with inhibitors for 30 min and washed thoroughly before incu-
bation with CD4+ T cells and added antigen. In some assays,
the activity of TLR5 was blocked using 10 μg/mL of neutralizing
anti-TLR5 monoclonal antibody (Invivogen) for 60 min before the
addition of flagellin and SM1 T cells.
Flow cytometric analysis
T-cell activation was examined using antibodies specific for
CD4, CD90.1, CD69, and CD25 (eBiosciences). In some exper-
iments, responding cells were permeabilized and stained with
anti-phospho-Syk (Cell Signaling Technology, Inc., Danvers, MA)
or isotype control antibodies. Cells were analyzed using a BD
Fortessa and data analyzed using FlowJo software (Treestar, Inc.,
Ashland, OR).
Cytokine ELISA
IL-2 and IL-6 cytokine production was examined in culture super-
natants collected at various time points after culture (3, 6, 9, 12,
and 24 h) using the mIL-2 BD Opt EIA detection kit (BD Bio-
sciences, San Diego, CA) and mIL-6 according to manufacturer’s
protocol. Absorbance was measured at 450 nm using a microplate
reader (Spectra Max M2, Molecular Devices, Inc., Sunnyvale, CA).
Protein immunoblot analysis
Enriched splenic DCs were cultured in 96- or 24-well plates with
purified flagellin (1 μg/mL or 10 ng/mL) and lysed at various time
points with RIPA buffer (Sigma) containing protease inhibitors
(Sigma). Whole-cell extracts were centrifuged, loaded onto
4–15% Tris/glycine gels (Bio-Rad, USA), and transferred to
polyvinylidene fluoride or nitrocellulose membranes (PVDF)(GE
Healthcare, Pittsburgh, PA, and Invitrogen). All antibodies (anti-
phospho PKC-delta, anti-caspase-1, anti-β-actin, anti–TEK, and
anti-phospho-IRS-1) were added at 1:1000 dilution, followed
by HRP secondary antibodies (Jackson Immuno Research, West
Grove, PA). ECL plus (GE Healthcare) was used as substrate and
blots examined using a Kodak Image Station.
Kinex antibody microarray preparation and data
analysis
DCs were enriched from the spleens of WT, TLR5-deficient, and
MyD88-deficient mice, using a CD11c+ DC isolation kit (Milteyni,
Auburn). CD11c+ DCs (2 × 106) from WT, TLR5-deficient,
and MyD88-deficient were subsequently treated with flagellin
(5 μg/mL) in culture for 15 min or left untreated. Stimulated
and unstimulated cells were then washed in cold PBS and the
lysates immediately prepared by sonication of for 5 min in Kinex
lysis buffer (20 mMMOPS, 2 mM EGTA, 5 mM EDTA, 30 mMNaF,
1 mM Na3VO4, 1 mM PMSF, 5 μM pepstatin A, 1 mM DTT, 1%
Triton X-100) supplemented with protease and phosphatase cock-
tail inhibitor. Samples were then centrifuged and approximately
100 μg of whole cell lysate from each sample were analyzed by
Kinexus Bioinformatics Corporation (Vancouver, Canada) using
the kinex antibodymicroarray service. For each phospho-antibody,
Z ratios were calculated according to Kinex Antibody microarray
protocols (Z ratio values of >1.0 is considered to be significant).
Statistical analysis
Data were determined to be normally distributed and differences
examined using InStat (GraphPad Software, La Jolla, CA). Data
were compared using unpaired t-test and were considered signifi-
cantly different with a p value of <0.05.
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